1 terminated, 1 withdrawn. 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Terminated 1, Withdrawn 1 |
Follow ThermoDox: new trials by email Literature Review of ThermoDox trials Research Report on ThermoDox
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Pilot Study of Thermodox and MR-HIFU for Treatment of Relapsed Solid Tumors Magnetic Resonance-Guided High Intensity Focused Ultrasound, Lyso-thermosensitive Liposomal Doxorubicin - Solid Tumors, Soft Tissue Sarcoma | Phase 2 | Withdrawn | Children's National Research Institute | 2022-11-10 | 2025-01-01 | |
| Phase 2 Study of Thermodox as Adjuvant Therapy With Thermal Ablation (RFA) in Treatment of Metastatic Colorectal Cancer(mCRC) Lyso-Thermosensitive Liposomal Doxorubicin, 5% Dextrose Solution, ThermoDox - Colon Cancer Liver Metastasis | Phase 2 | Terminated | Imunon | 2 | 2011-09-01 | 2022-10-13 |
Carcinoma (1) · Carcinoma, Hepatocellular (1) · Colonic Neoplasms (1) · Liver Neoplasms (1) · Neoplasms, Germ Cell and Embryonal (1) · Recurrence (1) · Rhabdomyosarcoma (1) · Sarcoma (1) · Sarcoma, Ewing (1) · Wilms Tumor (1)
Children's National Research Institute (1) · Imunon (1)
United States (2)
AeRang Kim, MD, PhD (1) · Nicholas Borys, M.D. (1)